Inhibition of Suicidal Erythrocyte Death by Indirubin-3’-Monoxime
Author(s) -
Chunqiu Liu,
Peipei Jiang,
Yuanhong Xu,
Meijuan Zheng,
Jinpin Qiao,
Xueyong Zhou,
Dake Huang,
Maohong Bian
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000487352
Subject(s) - phosphatidylserine , oxidative stress , chemistry , ionomycin , alexa fluor , flow cytometry , fluorescein isothiocyanate , reactive oxygen species , annexin , ceramide , apoptosis , cytosol , biochemistry , microbiology and biotechnology , biophysics , fluorescence , intracellular , biology , phospholipid , physics , quantum mechanics , membrane , enzyme
Qing Dai is a prized traditional Chinese medicine whose major component, indirubin, and its derivative, indirubin-3'-monoxime (IDM), have inhibitory effects on the growth of many human tumor cells and pronounced anti-leukemic activities. However, the effects of IDM on mature human erythrocytes are unclear. This study aimed to evaluate the potential impact of IDM on erythrocytes and the mechanisms underlying that impact.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom